CN102614291B - Decoction for treating chronic pelvic inflammatory disease - Google Patents

Decoction for treating chronic pelvic inflammatory disease Download PDF

Info

Publication number
CN102614291B
CN102614291B CN201210077230.9A CN201210077230A CN102614291B CN 102614291 B CN102614291 B CN 102614291B CN 201210077230 A CN201210077230 A CN 201210077230A CN 102614291 B CN102614291 B CN 102614291B
Authority
CN
China
Prior art keywords
inflammatory disease
decoction
pelvic inflammatory
chronic pelvic
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210077230.9A
Other languages
Chinese (zh)
Other versions
CN102614291A (en
Inventor
孙春林
马玉凤
孙丽华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhong Pharmaceutical Group Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210077230.9A priority Critical patent/CN102614291B/en
Publication of CN102614291A publication Critical patent/CN102614291A/en
Application granted granted Critical
Publication of CN102614291B publication Critical patent/CN102614291B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of pharmaceutical formulation, in particular to decoction for treating chronic pelvic inflammatory disease. The decoction is prepared by raw materials including, by weight percentage, from 11 to 14% of phellodendron, from 11 to 13% of rhizoma atractylodis, from 10-14% of patrinia, from 10 to 13% of sargentg loryvine stems, from 6 to 9% of Chinese angelica, from 5 to 8% of red paeony roots, from 9 to 11% of salvia miltiorrhiza, from 9 to 11% of herba lycopi, from 3 to 6% of frankincense and from 6 to 8% of myrrh. After the raw materials are soaked in water, slag is removed, and then filtrate is obtained. The decoction does not have toxic and side effects, and is low in cost, fine in treatment effect and suitable for treating the chronic pelvic inflammatory disease.

Description

The decoction that is used for the treatment of chronic pelvic inflammatory disease
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of decoction that is used for the treatment of chronic pelvic inflammatory disease.
Background technology
As everyone knows, chronic pelvic inflammatory disease refers to female internal genital organs and around connective tissue, pelvic peritoneal chronic inflammatory disease.Its main clinical manifestation is menoxenia, leucorrhoea grow in quantity, waist abdomen pain and infertile etc., as formed chronic adnexitis, can touch lump.Often with the passing of time more not and can repeatedly not show effect, cause infertile, tubal pregnancy, chronic pelvic pain, have a strong impact on WomanHealth, and increase family and socioeconomic burden.Pelvic inflammatory disease is the commonly encountered diseases of women at fertile age, and in recent years, domestic sickness rate is on the rise.
Summary of the invention
Object of the present invention is exactly in order to overcome above-mentioned existing technical deficiency, provides a kind of and has no side effect, and cost is low, and therapeutic effect is good, is suitable for the Chinese patent medicine decoction of chronic pelvic inflammatory disease.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of decoction that is used for the treatment of chronic pelvic inflammatory disease, adopting Cortex Phellodendri, Rhizoma Atractylodis, Herba Patriniae, Caulis Sargentodoxae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Herba Lycopi, Olibanum, Myrrha is raw material, after soaking, the filtrate of removing slag to obtain, raw material forms and is by weight percentage: Cortex Phellodendri 11~14%, Rhizoma Atractylodis 11~13%, Herba Patriniae 10~14%, Caulis Sargentodoxae 10~13%, Radix Angelicae Sinensis 6~9%, Radix Paeoniae Rubra 5~8%, Radix Salviae Miltiorrhizae 9~11%, Herba Lycopi 9~11%, Olibanum 3~6%, Myrrha 6~8%.
The invention has the beneficial effects as follows, have no side effect, cost is low, and therapeutic effect is good, is suitable for chronic pelvic inflammatory disease.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
First by following component (% by weight), get clean Cortex Phellodendri 13.5, Rhizoma Atractylodis 11.9, Herba Patriniae 13.4, Caulis Sargentodoxae 12.3, Radix Angelicae Sinensis 8.2, Radix Paeoniae Rubra 7.3, Radix Salviae Miltiorrhizae 10.3, Herba Lycopi 10.9, Olibanum 4.9, Myrrha 7.3, getting every pair of gross weight of above-mentioned 10 taste raw materials is 195 grams, at room temperature 10 taste Chinese herbal medicine being added to tap water 900~1000ml soaks 5~6 hours, then boiling with high heat slow fire decocted to 100~120 minutes, filtrate 180ml removes slag to obtain, medicinal residues add water 200~300ml again, decoct 40~50 minutes, filtrate 40ml removes slag to obtain, be total to obtain 220ml medicine juice, make the decoction that is used for the treatment of chronic pelvic inflammatory disease, pack in aseptic vial, seal bottle cap is standby, 1 dose minute every day 2 times is oral, each (medicine) being taken before meal lukewarm water 110ml, take to clinical symptoms sign and disappear.
Chronic pelvic inflammatory disease is common gynecological disease, frequently-occurring disease, often due to acute stage or without obvious acute stage, onset is slow, patient is irregular medication often, or treatment time is not enough, above-mentioned reason causes antibacterial to produce certain drug resistance, is difficult for absorbing therefore general antibiotic unsatisfactory curative effect because local chronic inflammatory disease makes medicine simultaneously.Treatment of Chronic Pelvic Inflammatory Disease With TCM ancient books, without the name of pelvic inflammatory disease, according to its clinical characters, can sporadically appear in " invasion of the blood-chamber by heat ", " leukorrheal diseases ", " through sick pain ", " married woman's stomachache ", “ mass in the abdomen ", in the disease such as " infertile ".The traditional Chinese medical science think many because of menstrual period, puerperal vessels of the uterus hollow, wet, pyretic toxicity is evil takes advantage of a weak point, in the rich knot of deteriorated blood born of the same parents, the collaterals of the uterus impairment of chong and ren channels, good and evil are handed over and are striven and cause.Primary disease take wet, heat, the stasis of blood is Etiological, while therefore treating, mainly with clearing heat, detoxicating, dispelling dampness, blood-activating analgetic circulation of qi promoting is main.Cortex Phellodendri, Rhizoma Atractylodis be except damp-heat in lower-JIAO, Caulis Sargentodoxae, Herba Patriniae invigorate blood circulation heat clearing away, dredging collateral analgesia; Radix Angelicae Sinensis, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Herba Lycopi, Olibanum, Myrrha drug for invigorating blood circulation and eliminating stasis can reduce capillary permeability, and minimizing is oozed out, and suppress connective tissue proliferation, strengthen the softening absorption of inflammatory thing.All medicines share, and take " clearly ", " leading to " as main, and all medicines are played the effect of the dampness of invigorating blood circulation, clearing away heat to alleviate pain altogether.
The embodiment that each raw material of the present invention also can the listed ratio of according to the form below (percentage by weight) mixes realizes.Its processing technique is identical with embodiment 1.
Figure BSA00000688615500021
Below in conjunction with my institute, the clinical trial that Wendeng City, In Shandong Weihai central hospital carries out is done further, is described in detail the present invention:
1. case selection: the routine patient of clinical random selection 60,30~45 years old age; The course of disease is the shortest 3 months, the longest 10 years.
2. diagnostic criteria: (1) Western medicine diagnose standard meets the diagnostic criteria person of < < new Chinese medicine guideline of clinical investigations > > chronic pelvic inflammatory disease.(2) tcm diagnosis standard meets the guideline of clinical investigations > > syndrome of accumulated dampness-heat of < < new Chinese medicine treatment pelvic inflammatory disease, the diagnostic criteria person of Accumulation of Dampness Heat and Blood Stasis card.
3. Therapeutic Method: every day potion divide 2 times oral, each 110ml, every day, each once, 4 weeks was 1 course for the treatment of sooner or later, took continuously 3 courses for the treatment of.
4. curative effect judgement:
Recovery from illness: symptom, health check-up and gynecologial examination all recover normally, B ultrasonic prompting uterus adnexa is normal, pelvic hydrops or empyema disappear, increase thick, thicken fallopian tube and attenuate, the low echo disappearance in uterus;
Effective: transference cure or improvement, gynecologial examination has clear improvement, B ultrasonic prompting uterus is normal or loose, pelvic hydrops or empyema reduce or disappear, increase thick, thicken and streak fallopian tube obvious, enclosed mass dwindles or disappears;
Invalid: clinical symptoms and gynecologial examination local patholoic change be without improvement, B ultrasonic prompting metrauxe, hydrops or empyema reduce, and that fallopian tube increases is thick, thicken with streak and be not improved, and enclosed mass is without obviously dwindling.
5. therapeutic effect: the present invention treats 60 examples, takes medicine three courses for the treatment of, and result 39 examples of fully recovering, account for 65%; Effective 21 examples, account for 35%; Invalid 0 example, accounts for 0%, total effective rate 100%.

Claims (1)

1. a decoction that is used for the treatment of chronic pelvic inflammatory disease, it is characterized in that: adopting Cortex Phellodendri, Rhizoma Atractylodis, Herba Patriniae, Caulis Sargentodoxae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Herba Lycopi, Olibanum, Myrrha is raw material, after soaking, the filtrate of removing slag to obtain, raw material forms, Cortex Phellodendri 11~14%, Rhizoma Atractylodis 11~13%, Herba Patriniae 10~14%, Caulis Sargentodoxae 10~13%, Radix Angelicae Sinensis 6~9%, Radix Paeoniae Rubra 5~8%, Radix Salviae Miltiorrhizae 9~11%, Herba Lycopi 9~11%, Olibanum 3~6%, Myrrha 6~8%.
CN201210077230.9A 2012-03-12 2012-03-12 Decoction for treating chronic pelvic inflammatory disease Active CN102614291B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210077230.9A CN102614291B (en) 2012-03-12 2012-03-12 Decoction for treating chronic pelvic inflammatory disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210077230.9A CN102614291B (en) 2012-03-12 2012-03-12 Decoction for treating chronic pelvic inflammatory disease

Publications (2)

Publication Number Publication Date
CN102614291A CN102614291A (en) 2012-08-01
CN102614291B true CN102614291B (en) 2014-04-02

Family

ID=46554739

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210077230.9A Active CN102614291B (en) 2012-03-12 2012-03-12 Decoction for treating chronic pelvic inflammatory disease

Country Status (1)

Country Link
CN (1) CN102614291B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988617A (en) * 2012-12-06 2013-03-27 青岛文创科技有限公司 Traditional Chinese medicine composition for treating gynecological acute pelvic inflammatory disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703668A (en) * 2009-10-23 2010-05-12 成莉 Nano-silver infrared antibacterial aloe fabric umbilical cord for preventing pelvic inflammation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703668A (en) * 2009-10-23 2010-05-12 成莉 Nano-silver infrared antibacterial aloe fabric umbilical cord for preventing pelvic inflammation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
夏桂成教授治疗慢性盆腔炎的经验介绍;李瑾;《新中医》;20110430;第43卷(第04期);143-144 *
李瑾.夏桂成教授治疗慢性盆腔炎的经验介绍.《新中医》.2011,第43卷(第04期),143-144.

Also Published As

Publication number Publication date
CN102614291A (en) 2012-08-01

Similar Documents

Publication Publication Date Title
CN101884770B (en) Chinese medicinal preparation for treating urolithiasis and preparation method thereof
CN101912593B (en) Medicament for treating dysmenorrheal and preparation method thereof
CN102370725B (en) A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof
CN100569257C (en) Treat typhlitic Chinese medicine and preparation method thereof
CN103007124A (en) Chinese medicine preparation for treating gynecologic inflammation
CN102319397A (en) Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method
CN102423423B (en) Traditional Chinese medicine for treating urinary tract infection
CN102895561A (en) Traditional Chinese medical composition for treatment of restless leg syndrome
CN104784548A (en) Traditional Chinese medicine composition for treating cough and application thereof
CN103919960A (en) Internal use medicine for treating dysmenorrheal and preparation method thereof
CN102614291B (en) Decoction for treating chronic pelvic inflammatory disease
CN102716266B (en) Buffalo horn-unprocessed rehmannia-lithospermum-cortex dictamni medicinal decoction for treating anaphylactoid purpura
CN102389464A (en) Traditional Chinese medicine used for treating acute mastitis
CN102784234A (en) Traditional Chinese medicine composition for treating chronic urticaria
CN102743623B (en) Preparation method of traditional Chinese medicine irrigation solution for treating frequent micturition and urgent micturition type trichomonas vaginitis
CN102743686B (en) The scorching clearing capsule of a kind of basin
CN104997868A (en) Traditional Chinese medicine composition for treating damp-heat type liver disease
CN104644956A (en) Traditional Chinese medicine composition for treating cold congealing and blood stasis type dysmenorrheal and preparation method thereof
CN105233088A (en) Medicine for treating chronic pelvic inflammatory disease
CN102228643A (en) Traditional Chinese medicine composition for treating chronic prostatitis
CN104740040A (en) Traditional Chinese medicine decoction for treating irregular menstruation
CN1049134C (en) Chinese prepared medicine for curing apoplexy
CN102552758B (en) Decoction containing Semen plantaginis, Philippine Violet Herb and Chinese lobelia for chronic pelvic inflammatory disease
CN105288436A (en) Medicament for treatment of chronic eczema
CN104688916A (en) TCM (Traditional Chinese Medicine) composition for treating psoriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: WANG LIHUA

Free format text: FORMER OWNER: SUN CHUNLIN

Effective date: 20141218

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 264400 WEIHAI, SHANDONG PROVINCE TO: 637400 NANCHONG, SICHUAN PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20141218

Address after: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2

Patentee after: Wang Lihua

Address before: 264400 Wendeng, Shandong, Zhejiang Province, East Hill Road, No. 3, Wendeng Central Hospital, Weihai

Patentee before: Sun Chunlin

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151225

Address after: 225500 No. 1 Su Zhong Road, Jiangyan District, Jiangsu, Taizhou

Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd.

Address before: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2

Patentee before: Wang Lihua

CP01 Change in the name or title of a patent holder

Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500

Patentee after: Suzhong Pharmaceutical Group Co.,Ltd.

Address before: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500

Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd.

CP01 Change in the name or title of a patent holder